ADVOKS GLOBAL · KENYA
Charter for Kenya Medical Research Institute, 2026
57. Benefits
Edition: 2025-07-21 · In force
57. Benefits
(1)Where an intellectual property right reaches the stage of commercialization, a share of royalties accruing to the inventor or innovator shall be forwarded to the inventor or innovator in accordance with minimum requirements set out in the applicable laws.(2)Where financial benefits are derived from the transfer or licensing of intellectual property rights, any direct costs incurred including expenses relating to the generation of the invention, fees, and any other charges resulting from the application for, granting or maintenance of the intellectual property rights and in marketing the invention or innovation shall first be recovered by the owner of the intellectual property.(3)Awards for intellectual property beneficiaries shall continue to be paid to—(a)an innovator or inventor where the inventor has left the employment of the Institute or sponsoring entity as the case may be; and(b)the estate of the innovator or inventor where the inventor is dead.(4)An innovator or inventor or estate of the innovator or inventor shall, for purposes of subparagraph (3), notify the Institute or sponsoring entity of any changes in contact details.(5)Where an invention makes significant use of knowledge or resources that may be related directly to a particular community or area, the Institute or the sponsoring entity shall take the necessary action to ensure that any transfer or licensing of intellectual property rights to a person or entity is in the best interests of that community or area.